MedTrace Logo

Intra-articular Injections of Platelet-rich Plasma, Hyaluronic Acid, or Corticosteroids for Knee Osteoarthritis

NCT04980105 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2021-07-28

No results posted yet for this study

Summary

To assess if there are any differences among platelet-rich plasma, hyaluronic acid, and corticosteroid knee intra-articular injection regarding function and pain.

Conditions

  • Osteoarthritis, Knee

Interventions

BIOLOGICAL

Platelet-rich plasma

Two intra-articular injections of autologous platelets-rich plasma (PRP) in two weeks intervals between the first and the second injection.

DRUG

Hyaluronic acid

Two intraarticular injections of hyaluronic acid (60 mg) in two weeks intervals between the first and the second injection

DRUG

Methylprednisolone acetate injectable suspension (DEPO-MEDROL®)

Single methylprednisolone acetate intraarticular injection (DEPO-MEDROL® pfizer 80 mg) mixed with 3cc of (xylocaine 2% concentration)

Sponsors & Collaborators

  • University of Wasit

    lead OTHER

Principal Investigators

  • Usama A Al-Sari, PhD · UOW

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-02
Primary Completion
2021-09-01
Completion
2021-10-01
FDA Drug
Yes

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04980105 on ClinicalTrials.gov